Amifostine for Head and Neck Irradiation in Lymphoma

NCT00136474 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
75
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Dana-Farber Cancer Institute

Collaborators